Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | MME | P08473 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2230116 | 0.84 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10KMT2A | |
| SCHEMBL25457592 | 0.79 | ALDH1A1 (0.40) | SMN1; SMN2ALDH1A1MMEKMT2A | |
| SCHEMBL446634 | 0.77 | MGAM (0.42) | SMN1; SMN2ALDH1A1MMEHSD17B10KMT2A | |
| SCHEMBL9346762 | 0.77 | KMT2A (0.36) | SMN1; SMN2ALDH1A1MMELMNAKMT2A | |
| SCHEMBL222338 | 0.76 | SMN1; SMN2 (0.44) | SMN1; SMN2ALDH1A1MMELMNAHSD17B10 | |
| SCHEMBL12877143 | 0.76 | GAA (0.48) | ALDH1A1LMNAHSD17B10KMT2A | |
| SCHEMBL684579 | 0.76 | ALDH1A1 (0.33) | SMN1; SMN2ALDH1A1MMEKMT2A | |
| SCHEMBL4144659 | 0.75 | ALDH1A1 (0.36) | SMN1; SMN2ALDH1A1MMEKMT2A | |
| SCHEMBL23804658 | 0.75 | ESRRB (0.37) | SMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL7712990 | 0.75 | ESRRB (0.37) | SMN1; SMN2ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011090323-A2 | NOVEL PREPARATION METHOD OF 2-(2-N-BUTYL-4-HYDROXY-6-METHYL-PYRIMIDIN-5-YL)-N,N-DIMETHYLACETAMIDE | BORYUNG PHARMACEUTICAL CO., LTD (KR) | 2011-07-28 | — | — | WO | disclosed |